Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.86 USD | +0.15% | +1.18% | -38.86% |
15/05 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
14/05 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.86% | 19Cr | |
+18.72% | 12TCr | |
+14.19% | 11TCr | |
-4.93% | 2.42TCr | |
+3.23% | 2.28TCr | |
-10.44% | 1.8TCr | |
-41.74% | 1.64TCr | |
-13.31% | 1.64TCr | |
+2.44% | 1.36TCr | |
+27.89% | 1.17TCr |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Inc. Appoints Marco Brughera to the Board of Directors